自评版疾病管理和康复量表的本土化修订及评价

Chinesization and Evaluation of Client Versions of the Illness Management and Recovery Scale

目的:对英文版和繁体中文版自评版疾病管理和康复量表(IMRS)进行简体中文本土化修订,并评价译本的信度和效度,以形成适用于中国大陆地区重性精神障碍患者自我评价的量表。方法:对疾病管理和康复量表英文版(IMRS-EV)进行简体中文翻译,同时对香港医院管理局作业治疗师改编的繁体中文版本进行简体中文转化,整合翻译和转化的成果形成初稿后,在3位资深精神科临床医生指导下改进为简体中文版量表(IMRS-CV),用IMRS-CV对103名精神分裂症住院患者进行调查,采用探索性因子分析确定量表结构,同时采用相关性分析、Cronbachα系数及分半系数进行信度和效度的分析。结果:IMRS-CV由6个因子组成,因子累计方差贡献率为64.47%,量表的Cronhach’sα系数0.64,分半系数为0.63。各因子间及与总分间的相关性较高,具有较好的聚集效度和区分效度。结论:IMRS-CV的译本得到3位资深精神科临床医生的认可,且在患者使用过程中无明显困难,统计分析提示该译本有较好的信度和效度,可用于疾病管理和康复项目中。

Objective:To chinesize both English version and classic Chinese version of the Illness Management and Recovery Scale(IMRS)with simplified Chinese.To evaluate the reliability and validity of the translated scale and make it applicable to patients with severe mental diseases in China's Mainland.Methods:Firstly,we translated the English version of IMRS(IMRS-EV)into simplified Chinese version(IMRS-CV)directly and translated the classical Chinese version of IMRS from Hong Kong into simplified Chinese at the same time.A draft of the IMRS-CV was developed after combining different translations.Then,we invited three experienced psychiatrists to improve the draft.After that,103 patients with schizophrenia in the ward were surveyed by the IMRS-CV.We used exploratory factor analysis to determine the factors of IMRS-CV.Reliability and validity were accessed using correlation analysis,Cronhach'sαcoefficient,and split-half coefficient.Results:The IMRS-CV was consisted of 6 factors with 64.47%variance explained.The Cronhach'sαcoefficient was 0.64 and the split-half coefficient was 0.63 for IMRS-CV.We observed high level of correlation between individual item of IMRS-CV and factors,indicating good convergent validity and discriminant validity were also observed.Conclusion:IMRS-CV was approved by all three psychiatrists and no unsolvable problem was met when surveying the patients.With good reliability and validity,the IMRS-CV can be used in the Illness Management and Recovery program for patients with severe mental diseases in China's Mainland.